Myeloma cell lines and primary cells exhibit variable BCL2 family member expression and dependency, and in vitro venetoclax sensitivity in myeloma cells correlates to the relative expression of alternative pro-survival proteins, particularly MCL1 [113–115]. Here, BCL2 is linked to plasma cell myeloma.